Clinical Trials Directory

Trials / Completed

CompletedNCT02954835

Negative Pressure Therapy for Groin Wounds

Negative Pressure Therapy for Closed Groin Wounds in Patients Undergoing Vascular Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Englewood Hospital and Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare wound infection rates between negative pressure therapy (Prevena) and the traditional sterile dry dressing among patients undergoing vascular surgery involving groin incisions.

Detailed description

This is a prospective, investigator-initiated, post-market data collection study comparing wound infection rates among patients undergoing vascular surgery involving groin incisions. Patients will be randomized on the day of surgery to receive the traditional sterile dry dressing or Prevena. Patients with the traditional dressing will undergo dressing changes as per the standard protocol with the first dressing change at postoperative day 2 or 3, or at the discretion of the attending surgeon. The patients with Prevena dressing will have the dressing in place for 5 to 7 days postoperatively and removed before discharge, or at the first outpatient visit. The Primary Objective of this study is to see if using negative pressure therapy decreases the rate of infection. The Secondary Objectives will include multivariate analysis to understand which patients may have a compounded benefit from Prevena (e.g. smokers, diabetics, and obese patients). The Prevena System is an FDA approved bandage and will be used in this study for on-label purposes.

Conditions

Interventions

TypeNameDescription
DEVICEPrevenaPrevena is a sterile silver dressing. On top of the silver dressing is an adhesive plastic, which is connected to a therapy unit through a short length suction tube.
DEVICETraditional DressingSterile gauze dressing secured by tape.

Timeline

Start date
2016-12-01
Primary completion
2019-09-03
Completion
2019-09-03
First posted
2016-11-03
Last updated
2020-02-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02954835. Inclusion in this directory is not an endorsement.